Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
AMAG Pharmaceuticals, Inc. (NQ: AMAG)
21.94 USD  -0.46 (-2.05%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about AMAG Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 Next >
AMAG Pharmaceuticals Provides Business Update
January 09, 2011
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Present at the 29th Annual J.P. Morgan Healthcare Conference
January 05, 2011
from Business Wire News Releases
Analyst Research on Immucor Inc. and AMAG Pharmaceuticals Inc. - Diagnostic Substances Sector Primed to Grow
January 05, 2011
from Marketwired News Releases
AMAG Pharmaceuticals Announces Update to Feraheme® Label
November 29, 2010
from Business Wire News Releases
Top Percentage Gainers in Morning Session 11/29/10 (AMRN, VOLT, IRE, AMAG, SGMO) by EquityMarketReport.com
November 29, 2010
from EmailWire.Com Press Releases
Stock Upgrades 11/29/10 (American Eagle Outfitters, AMAG Pharmaceuticals, Sunstone Hotel Investors, Kindred Healthcare, SBRA) by EquityMarketReport.com
November 29, 2010
from EmailWire.Com Press Releases
AMAG Pharmaceuticals, Inc. to Host Conference Call on Monday, November 29, 2010 at 8:00 a.m. ET to Provide an Update on Feraheme Label Discussions
November 26, 2010
from Business Wire News Releases
Palo Alto Investors Calls on Board of AMAG Pharmaceuticals to Use Excess Cash to Repurchase Stock and Increase Stockholder Value
November 22, 2010
Palo Alto Investors Believes Repurchase is in Best Interest of Stockholders Read More
from Business Wire News Releases
Equity Research on Akorn Inc. and AMAG Pharmaceuticals Inc. -- Diagnostic Substances Sector Sees Mixed Earnings Season so Far
November 10, 2010
from Marketwired News Releases
AMAG Pharmaceuticals Announces Financial Results for the Third Quarter Ended September 30, 2010 and a Restructuring Plan to Reduce Operating Expenses
October 28, 2010
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Third Quarter on October 28, 2010 at 5:30 p.m. ET
October 22, 2010
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. Announces Data Presentations at the American Society of Nephrology (ASN) Renal Week Meeting
October 21, 2010
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. Announces Data Presentations at the American Society of Nephrology (ASN) Renal Week Meeting
October 21, 2010
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
September 07, 2010
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Present at Canaccord Genuity 30th Annual Global Growth Conference
August 03, 2010
from Business Wire News Releases
AMAG Pharmaceuticals Announces Financial Results for the Second Quarter and Six Months Ended June 30, 2010
July 28, 2010
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Second Quarter on July 28, 2010 at 4:30 p.m. ET
July 21, 2010
from Business Wire News Releases
AMAG Pharmaceuticals and Takeda Announce Acceptance of Submission of Feraheme® Marketing Authorization Application to the European Medicines Agency
June 29, 2010
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
June 04, 2010
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Present at the 2010 Citi Investment Research Global Healthcare Conference
May 20, 2010
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Present at the Bank of America Merrill Lynch 2010 Healthcare Conference
May 03, 2010
from Business Wire News Releases
AMAG Pharmaceuticals Announces First Quarter 2010 Financial Results
April 27, 2010
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. Appoints Gary J. Zieziula as Executive Vice President and Chief Commercial Officer
April 27, 2010
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Quarter Ended March 31, 2010
April 21, 2010
from Business Wire News Releases
AMAG Pharmaceuticals to Host Conference Call to Discuss Strategic Collaboration with Takeda Pharmaceutical Company for Feraheme® in Select Ex-US Territories
April 01, 2010
from Business Wire News Releases
AMAG Pharmaceuticals and Takeda Pharmaceutical Company Announce Strategic Collaboration for Feraheme® in All Therapeutic Indications in Select Ex-US Territories, Including Europe
April 01, 2010
from Business Wire News Releases
Abraham, Fruchter & Twersky, LLP Warns Investors That It is the Only Law Firm That Has Filed a Class Action Lawsuit Against AMAG Pharmaceuticals, Inc.
March 25, 2010
from Business Wire News Releases
AMAG Pharmaceuticals under Investigation for Potentially Defrauding Shareholders, Says Hagens Berman
March 24, 2010
from Business Wire News Releases
Brower Piven Encourages Investors Who Have Losses in Excess of $200,000 From Investment in AMAG Pharmaceuticals, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Laws
March 24, 2010
from Marketwired News Releases
Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG)
March 22, 2010
from Marketwired News Releases
< Previous 1 2 3 4 5 6 7 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here